2024-07-24 19:00:03
In partnership with Arcturus Therapeutics, a global late-stage clinical mRNA medicines and vaccines company, CSL received approval by Japan’s Ministry of Health, Labor and Welfare (MHLW), for ARCT-154, a self-amplifying mRNA (sa-mRNA) COVID-19 vaccine for initial vaccination and booster for adults 18 years and older in Japan.
With the approval of ARCT-154, CSL now offers an even more comprehensive portfolio of innovative vaccines that combat respiratory viral diseases.
What is Messenger RNA?
Messenger RNA (mRNA) vaccines help protect against infectious diseases by providing a blueprint for cells in the body to make a protein to help our immune systems recognize and fight the disease.
Different from standard mRNA vaccines, self-amplifying-mRNA vaccines instruct the body to make more mRNA and protein to achieve a higher immune response. Self-amplifying mRNA vaccines contain a smaller dose of mRNA yet yield a strong immune response.
Kareena Kapoor is working with Raazi director Meghna Gulzar for her next film. The project,…
2024-11-09 15:00:03 WEST LAFAYETTE -- Daniel Jacobsen's second game in Purdue basketball's starting lineup lasted…
2024-11-09 14:50:03 Rashida Jones is remembering her late father, famed music producer Quincy Jones, in…
2024-11-09 14:40:03 A silent German expressionist film about vampires accompanied by Radiohead’s music — what…
Let's face it - life can be downright stressful! With everything moving at breakneck speed,…
Apple’s redesigned Mac Mini M4 has ditched the previous M2 machine’s SSD that was soldered…